PARKE DAVIS FDA Approval ANDA 087131

ANDA 087131

PARKE DAVIS

FDA Drug Application

Application #087131

Application Sponsors

ANDA 087131PARKE DAVIS

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL0.025MG;2.5MG0DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATEATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE

FDA Submissions

ORIG1AP1981-07-17

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 87131
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.